Rheumatoid factor and anti-CCP are two antibody tests commonly ordered when rheumatoid arthritis is suspected. Here is what each one measures, how to interpret them together, and what your doctor will likely do next.
Select whether each result was negative, weakly positive, or strongly positive. The 2010 ACR/EULAR criteria define low positive as above the upper limit of normal but no more than three times that limit, and high positive as more than three times the upper limit of normal. If your report shows a number, compare it to the reference range on your lab report to determine which category applies. The combination of both tests matters more than either alone.
Both RF and anti-CCP are antibodies, proteins your immune system produces. In autoimmune disease, the immune system sometimes makes antibodies that target the body's own tissues. These two tests check for specific antibodies associated with rheumatoid arthritis (RA).
Neither test confirms RA on its own, and neither rules it out. A positive result without joint symptoms means much less than a positive result in someone with swollen, stiff joints.[1] Diagnosis is still made by a clinician using the full clinical picture. Persistent joint swelling itself is a reason for rheumatology referral, and that referral should not be delayed waiting for blood test results.[2]
RF is an antibody that targets the Fc portion of IgG, part of your own immune system. It has been used in RA workups for decades but is considered nonspecific because it appears in many conditions beyond RA.
RF is positive in roughly 60 to 70 percent of people with RA, though these figures vary by assay and population. It also appears in many other conditions and in healthy people, which limits its diagnostic usefulness when used alone.[2] A positive RF result must be interpreted in light of the full clinical presentation, specifically how likely it is the patient actually has RA based on their symptoms and exam.
The level matters. A high positive RF is more likely to be clinically meaningful than a weakly positive one. A low or borderline RF in the absence of joint swelling is frequently not significant.[2]
RF can also be temporarily positive after acute infections. Transient RF elevations can occur and often do not indicate chronic autoimmune disease, though they should be interpreted in the context of the overall clinical picture.[2]
Anti-CCP (also called ACPA, or anti-citrullinated protein antibodies) is usually more specific than RF for RA, so it often carries more diagnostic weight when positive, especially alongside joint symptoms. In clinical practice, RF and anti-CCP are considered complementary tests rather than one replacing the other.
Anti-CCP has a sensitivity of about 60 to 70 percent for RA, similar to RF, but its specificity is far higher. A meta-analysis of 37 studies found anti-CCP had specificity of approximately 95 to 97 percent for RA, meaning it is strongly associated with RA and much more specific than RF.[3] Even so, a positive anti-CCP does not diagnose RA by itself. Diagnosis is still made using the full clinical picture, including symptoms, physical exam, and imaging.
One particularly useful feature: anti-CCP can appear in the blood years before symptoms of RA develop.[4] A high-positive anti-CCP is also associated with more aggressive RA and a greater likelihood of needing biologic therapy.[5]
The most diagnostically significant combination. When both are positive in a patient with synovitis, this combination is strongly associated with RA and warrants prompt rheumatology evaluation. Positive results can still occur in other autoimmune diseases, and the diagnosis is confirmed by the rheumatologist using the full clinical picture.[2]
This combination is also associated with more aggressive disease and a higher risk of joint erosion over time.[5]
Raises clinical concern for RA, possibly at an early stage. Because anti-CCP is so specific for RA (around 95 to 97 percent[3]), a positive result without RF substantially raises concern for RA, particularly with joint symptoms. A positive anti-CCP alone does not confirm RA, but it does warrant specialist evaluation.
This pattern is common in early RA, where RF has not yet become detectable. Anti-CCP can precede joint symptoms by years.[4]
Less specific. Many explanations other than RA. RF positive with anti-CCP negative is the most common pattern in non-RA conditions. Other autoimmune diseases, infections, and older age can all cause this combination.
RA is still possible, but other causes of inflammatory arthritis must be excluded.[2] A low or weakly positive RF without supporting clinical findings is often not significant.
Seronegative: does not rule out RA. About 20 to 30 percent of RA patients are negative for both tests.[2] If you have significant, persistent joint swelling, a rheumatology referral is appropriate based on your symptoms alone, and should not wait for blood test results.
| Category | Examples | Notes |
|---|---|---|
| Other autoimmune conditions | SLE (20-30%[2]), Sjogren's disease, mixed connective tissue disease, scleroderma | RF can be elevated in many rheumatic diseases. Anti-CCP is more specific for RA. |
| Infections, especially hepatitis C | Hepatitis C is particularly important. Very high RF titers can occur with hepatitis C, especially in mixed cryoglobulinemia. Also hepatitis B, parvovirus B19, subacute bacterial endocarditis.[2] | Transient RF during illness can occur and often does not indicate chronic autoimmune disease. Hepatitis C and B serologies should be checked in selected patients with positive RF, especially when anti-CCP is negative.[2] |
| Older age | Healthy adults over 70 | RF positivity rises with age in healthy people, reaching 10-25% in adults over 70. A low positive RF in an older adult without joint swelling is often incidental.[2] |
| Other chronic conditions | Sarcoidosis, primary biliary cholangitis, chronic lung disease | Various chronic inflammatory conditions can produce a positive RF as a nonspecific finding. |
Not necessarily, and in many cases the answer is no. A positive RF without a positive anti-CCP is the most common pattern in conditions other than RA, including Sjogren's disease, hepatitis C, and older age.[2] Without a positive anti-CCP or clear synovitis on physical exam, a positive RF alone does not diagnose RA.
Your doctor will look at the full picture: which joints are involved, whether there is actual swelling on exam, and your other labs. Serial repeat RF testing without new clinical information is generally not helpful.[2]
Yes, though changes are often slow. RF levels can decrease with effective RA treatment over months to years. Anti-CCP tends to be more stable and may remain elevated even when disease is well controlled. Neither test is used to make day-to-day treatment adjustments. Your rheumatologist will primarily track your symptoms, joint counts, and CRP or ESR to gauge disease activity rather than repeating RF or anti-CCP frequently.
This warrants thoughtful monitoring. Anti-CCP can appear years before RA symptoms develop.[4] A positive anti-CCP without symptoms places you in a higher-risk category, but does not mean RA is inevitable.
Your doctor will likely examine your joints carefully, check labs in a few months, and educate you about early warning signs: joint swelling, morning stiffness lasting more than 30 minutes, or grip weakness. A rheumatology referral is reasonable at this stage for a baseline evaluation.
A high RF titer with synovitis is more diagnostically meaningful than a low or borderline positive. In confirmed RA, higher RF levels have been associated with more aggressive joint disease and higher rates of erosion.[5]
However, a very high RF can also occur in other conditions, particularly Sjogren's disease and hepatitis C, where RF titers can be very high especially when mixed cryoglobulinemia is present. A high titer alone does not confirm RA without supporting clinical evidence.
Yes. About 20 to 30 percent of RA patients are seronegative, meaning both tests are negative.[2] Seronegative RA is a real diagnosis made on clinical grounds, based on the pattern of joint involvement, physical exam, imaging, and response to treatment.
If you have significant, persistent joint swelling, a rheumatology referral is appropriate based on your symptoms alone. Referral should not be delayed while waiting for blood test results, and a negative result should not stop you from pursuing evaluation if your symptoms are convincing.
ANA is sometimes ordered when the differential diagnosis includes lupus, Sjogren's syndrome, mixed connective tissue disease, or another connective tissue disease that can cause joint pain or stiffness similar to early RA. It is not a specific test for RA and does not support or confirm an RA diagnosis on its own.
A negative ANA lowers the likelihood of lupus and some other connective tissue diseases, but does not fully exclude them, since ANA can occasionally be negative in certain lupus subsets. The most useful role of ANA here is helping your doctor consider other autoimmune causes of your symptoms rather than narrowing in on RA specifically.[2]